Both in Pharmaceuticals
Jade Biosciences vs Rigel Pharmaceuticals Inc. (New)
Over the past year JBIO returned +64.5% and RIGL returned +70.1%; their daily moves had a correlation of 0.30.
JBIO +64.5% RIGL +70.1%Growth of $1, one year, split-adjusted
| Metric | JBIO | RIGL |
|---|---|---|
| Price | $14.18 | $48.89 |
| Market cap | $901.8M | $913.3M |
| Today | −1.18% | −0.95% |
| 1 month | −32.0% | +5.2% |
| 6 months | +6.9% | +90.1% |
| Year to date | −8.1% | +14.1% |
| 1 year | +67.2% | +70.8% |
| Revenue growth (YoY) | — | −22.6% |
| Gross margin | — | 89.2% |
| Net margin | — | 22.0% |
| P/E (TTM) | — | 2.8× |
| Price / sales | — | 3.3× |
| Net cash | $461.2M | $56.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.9% | 40.5% |
| Short % of float | 26.6% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).